Biomarin Pharmaceutical Inc (BMRN)
66.63
+0.36
(+0.54%)
USD |
NASDAQ |
Dec 24, 16:00
Biomarin Pharmaceutical Cash from Investing (Quarterly): -16.16M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | -3.845B |
| Biogen Inc | -1.181B |
| Pfizer Inc | -2.057B |
| Bristol-Myers Squibb Co | -219.00M |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 221.48M |
| Cash from Financing (Quarterly) | -499.12M |
| Free Cash Flow | 300.88M |
| Free Cash Flow Per Share (Quarterly) | 1.016 |
| Free Cash Flow to Equity (Quarterly) | 694.63M |
| Free Cash Flow to Firm (Quarterly) | 200.30M |
| Free Cash Flow Yield | 2.30% |